TRCT
MANE

Tower Research Capital (TRC)’s Veradermics Inc MANE Stock Holding History

Tower Research Capital (TRC)’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$632 Buy
+10
New +$504 ﹤0.01% 4819

Other funds holding MANE

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

Tower Research Capital (TRC)'s MANE Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in Veradermics Inc (MANE) in Q1 2026: 10 shares worth $632. The stake represents ﹤0.01% of the portfolio and ranks #4819 among its holdings.

81 funds tracked by Wall St. Rank hold MANE as of Q1 2026.

  • Tower Research Capital (TRC) held 10 shares of Veradermics Inc worth $632 as of Q1 2026.
  • Veradermics Inc was a new Tower Research Capital (TRC) position in Q1 2026.
  • Veradermics Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4819 holding.
  • 81 funds tracked by Wall St. Rank held Veradermics Inc as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.